J B CHEMICALS PHARMACEUTICALS LTD Q2 RESULTS
Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 27.8%.
Grasim Industries Q1 Results: Profit slides by a fourth to Rs 1,189 crore on investment in paints ops
The flagship company of the Aditya Birla launched its paints operations ‘Birla Opus’ towards the end of the March quarter, and April-June was its first quarter of full operations. The company has spent Rs 7,795 crore on its paints business as of June-end, approximately four-fifth of the total planned expenditure for these operations.
Grasim Q1 Results: Firm reports Rs 52 cr standalone loss versus Rs 355 cr yr-ago profit
Grasim experienced a Rs 52.12 crore standalone loss in the June 2024 quarter, falling from a Rs 355 crore profit a year ago. Revenue grew 11% YoY to Rs 6,894 crore, driven by its diversified businesses. However, the chemicals segment saw a revenue decrease. Grasim shares were up 1.17% to Rs 2,574.45 on NSE.
Q1 results today: Grasim, Info Edge among 306 companies to announce earnings on Friday
The earnings season for the first quarter has commenced with 306 companies, including Trent, Grasim, and Info Edge, reporting their results. Grasim's net profit is projected to range from Rs 104-231 crore, despite a potential YoY decline. Revenue is expected to increase, though profits may be hindered by higher losses in some divisions.
Grasim Industries Q1 preview: Revenue uptick seen at 17-25% YoY, PAT may fall on losses in VSF, paints biz
Grasim Industries' net profit for Q1 ending June 30, 2024, is projected to be between Rs 104 crore and Rs 231 crore, with revenue expected to see a 17%-25% YoY increase. However, losses in the VSF and paints segments are likely to pull down the PAT figures, compounded by weak operating margins.
Q1 results this week: ITC, SBI, TaMo, Zomato among 130 firms to announce earnings
This week, several prominent companies released their June quarter financial results. Firms like ITC, SBI, Adani Ports, Tata Motors, and M&M showcased their reports between July 29th and August 3rd. The updates offered a glimpse into their quarterly performance, engaging the attention of investors and stakeholders.
- Go To Page 1
J&J Q2 Results: Pharma major beats Wall Street estimates on strong drug sales
Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara.
Petro Carbon and Chemicals stock lists with 75% premium over IPO price
Petro Carbon and Chemicals, under the Atha Group, dominates the B2B market by supplying calcined petroleum coke to a wide range of industries, ensuring high-quality carbon anodes for aluminum smelting. Its strategic growth through vertical integration and tech innovation secures its position in the market.
Midcaps stocks for long term investors: 5 stocks from different sectors with right financial & growth matrix and upside potential of up to 49%
Buying quality stocks should be one of the basic principles while investing in markets. But when one is buying mid-cap stocks this principle becomes even more important for multiple reasons. At this point of time, when valuations are high and small corrections can lead to strong negative reactions in stock prices. So, while capital gains is the objective, never lose the perspective of protecting capital from sudden shocks. Now how does one do it? Look at the underlying business which is best understood by going through its annual report and look at a certain basic ratio in order to figure out how much return that underlying business can generate in best and worst case.
Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 31 %
There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Will this correction continue even longer ? It would probably be clear by the end of the day as the election result finally gets settled. Instead of focusing on how much nifty or bank nifty or any other index is down or up, focus on the fact that whether the sector or company is doing well and will it do well in future because the fundamental operating matrix of that sector has changed for better. Because volatile phases come and go, changes in the operating matrix don't happen every day. Pharmaceutical is one sector where there is a fundamental change taking place and it has happened after 8 to 10 years of restructuring and painful readjustment. So, it would be worthwhile to have them on watchlist and if the market remains volatile then it is a sector which probably has a higher probability of outperforming.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 39%
Just before the start of the final phase of the general elections 2024 was to take place, there was a clear indication that it is bulls who are in control of the market. There are no two opinions, that a continuity in policy making will make the markets move upward very sharply. A glimpse of that will come in Monday’s trading session, when the impact of the exit poll result gets played out. So, with the base case assumption that the policy making will continue, we take things forward but continue with our principle stand that If one is taking fresh exposure to equity, ensure that there is some level of quality as far as the business and fundamentals are concerned.These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Staying with good business & strong management: 5 largecap stocks from different sectors with upside potential of up to 37%
After a phase of calm, volatility is back on the street. Somehow word volatility got associated with bearish trend, while it might appear strange to some, the fact is that even volatility has a bias and that can be toward bulls also. That is the reason why in this volatile phase, Nifty made a new high. So, rather than fearing a word it is better to understand it. Similarly when it comes to investing, it is important to understand that while events can impact the price in the short term. In the long term, things which matter is the underlying business, strength and quality of the balance sheet, ability and experience of the management. Whether it is pre-election or post election, always have a look at the above three when investing your hard earned money.
Stocks with tailwinds called advantage India: 5 largecap stocks from 3 different sectors with an upside potential of upto 36 %
In terms of valuations and sentiment we are not far from the place where we were in the last quarter of 2023 or early part of this year. When it was not possible to find stocks which can be called as “fairly valued” forget “undervalued”, and the sentiment was very bullish. The only difference between then and now is that we have election results which are coming up. Surely a confirmation on 4th June that continuity in the policy making is a big factor. But there is another thing which long term investors need to look at before investing. Whether the company or the sector has an advantage due to India as a country. A well known example, which has been present for decades is that of the IT industry. India as a country is a factory of software engineers, and that is our strength. So when investing for the long term, look at sectors where we have some strong tailwinds due to our human capital.
Q4 results this week: Tata Steel, LIC, IRCTC, Apollo Hospitals Enterprise, and Bharat Dynamics
Several companies, including Tata Steel, LIC, and IRCTC, will release their March quarter report cards this week.
Strong balance sheet & long runaway of sectoral growth: 5 largecap stocks from different sectors with upside potential of up to 37%
When investing in any stocks, be it a large, small or medium cap there has to be one strong reason why one should invest in. It could be a strong balance sheet, strong brand, long runway of growth for the sector. Because if one of these are present in a company then the short term volatility in the market does not matter. They come and go and finally these stocks are able to deliver returns. Especially at a time when the index is forming a new high and sentiment all bullish, it is more important to stay cautious because however strong a bull run might be, it has phases of correction like the one we saw in March and as recently as last week. If one is staying with quality stocks, the probability of faster recovery when bulls are back is high. We look at 5 stocks from different places where either one or more of the three things are present.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Staying bullish and hedging go hand in hand: 5 mid cap stocks from different sectors with potential upside of up to 39%
At this point of time when the street is juggling with its own fear and anxiety and waiting for the election results, the mid-caps segment of the market is witnessing some profit booking/ rational shifting/ consolidation. A part of that is happening because of the fact that the street is reacting and adjusting to Q4 numbers. The way stocks are moving, there is no one trend in mid-cap space. So there are many sub segments which are getting formed in mid-cap space and given the mix of head and tailwinds, this segmentation is likely to stay till election results. So, one will have to do two things, one be bullish but be more selective and focus on managing risks and hedge for short term and think from long term perspective.
Q4 results this week: Adani group to lead as 211 companies will declare earnings
With 211 companies announcing quarterly results this week, investors are particularly watching out for major names like Kotak Mahindra Bank, DMart, Ultratech Cement, Indian Oil, and many others across various industries.
Q3 results this week: ITC, Adani Ports, Bajaj Finance, IndiGo, SBI, Tata Motors and others
ITC, Bajaj Finance, NTPC, Adani Green Energy, Bharat Electronics, Punjab National Bank, GAIL, Bharat Petroleum, Corporation, Vodafone Idea, Marico, Petronet LNG, Nippon Life India Asset Management, Tata Investment Corporation, Piramal Enterprises, R R Kabel, Aditya Birla Sun Life AMC, Maharashtra Seamless, Nuvoco Vistas Corporation, Godfrey Phillips India, among others will report their December quarter numbers on Jan 29
J&J Q4 Results: Profit edges past Street view after deals delay Stelara competition
Johnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug Stelara, which is expected to face fresh U.S. competition from biosimilar versions next year.
RIL Q3 results today: What to expect from the conglomerate; how to trade the stock?
RIL Q3 results today: Reliance Industries (RIL) is set to release its December quarter earnings, and investors are cautious. RIL shares have gained 6% in January. The earnings will determine the sustainability of the gains. Consolidated revenue is expected to rise 5% YoY to Rs 2.31 lakh crore. Consolidated net profit is expected to grow 9.3% YoY to Rs 17,257 crore. Reliance Jio Infocomm and the retail business are expected to perform well, while the oil-to-chemicals business may see a drop in earnings. RIL shares have fallen post-earnings in the past.
Buy J B Chemicals & Pharmaceuticals, target price Rs 1,800: Prabhudas Lilladher
JBCP’s long term growth drivers remain intact led by 1) geographical expansion of legacy brands 2) improvement in MR productivity 3) scale-up in acquired portfolio 4) launch of new products & therapies 5) rise of contract manufacturing business and 6) improvement in FCF generation.
Q2 Results on Friday: What to expect from M&M, Coal India, LIC and Hindalco
Among index majors, Coal India, Eicher Motors, Hindalco Industries, Mahindra & Mahindra, and Oil and Natural Gas Corp are set to release their quarterly numbers.
Q2 results this week: Adani Ports, Tata Power, LIC, RVNL, M&M and others
Power Grid, Shree Cements, Trent, Zydus Lifesciences, Info Edge (India), Indian Railway Catering & Tourism Corporation, Cummins India, Alkem Laboratories, UNO Minda, Prestige Estates Projects, among others will release their Q2 earnings on November 7
Dr Reddy's Labs Q2 Results: Co reports highest-ever net profit at Rs 1480 crore
Dr Reddy's on Friday reported its highest-ever quarterly net profit of Rs 1480 crore in Q2FY24, a jump of 33% year-on-year (YoY) driven by generics sales growth in the US and Europe.
Q4 results this week: Adani Ports, Adani Transmission, IRCTC, Apollo Hospitals and others
Nifty stocks fell short of the estimated 10.6% with 9.7% while Nifty 500's earnings improved by 11.7% compared to the estimated 8.9%, indicating the outperformance of mid- and small-caps. Equity markets will take cues from macro data, US debt negotiations, and central bank policy meetings. Companies such as Adani Transmission, IRCTC, NHPC, Torrent Power, and Mazagon Dock Shipbuilders are among many to release the Q4 earnings in the last week of May.
Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%
As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when market breadth is also getting bearish in volatile mode. Amongst others, pharma is one of them. Even during this period, many mid-cap stocks from different sectors which have seen improvement in their scores and their prices have also been in positive territory. We have taken 5 pharma stocks from mid-cap space, which witnessed an improvement in their scores. A score improvement coming in a volatile earning season along with the fact that valuations are still very high on an over basis is something worth looking into. ET screener powered by Refinitiv’s Stock Report Plus applies different algorithms & filters to all BSE and NSE stocks, and lists down stocks which fulfill the various criteria as specified into the algorithms & filters.
Buy J B Chemicals & Pharmaceuticals, target price Rs 2260: Edelweiss Financial Services
Stock has broken out of a month long consolidation, making a base at 2,000 levels
Corporate Radar: Ajanta Pharma to trade ex-dividend, LIC, M&M results and more
Shares of Ajanta Pharma (Rs 7 per share), GMM Pfaudler (Re 1 per share), Siyaram Silk (Rs 4 per share) and Nikko Parks (Re 0.4 per share) will trade ex-dividend. Shares of GPT Infraprojects will trade ex-bonus in respect of the bonus share issue in the ratio of 1:1.
Load More
